SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000014272-18-000044
Filing Date
2018-02-05
Accepted
2018-02-05 18:20:11
Documents
2
Period of Report
2018-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151787279657237.html 4  
1 FORM 4 wf-form4_151787279657237.xml 4 4291
2 EXHIBIT 24 - MATTHEW EMMENS POWER OF ATTORNEY ex-24.htm EX-24 1433
  Complete submission text file 0000014272-18-000044.txt   7182
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Issuer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST., ATTN: GENERAL COUNSEL CAMBRIDGE MA 02139
Business Address
Emmens Matthew (Reporting) CIK: 0001298332 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-01136 | Film No.: 18575615